Latest Breaking News On - Current clinical - Page 1 : comparemela.com

InGeneron Announces Critical In-Depth Analysis of the Results from a Recently Published 480-Patient Phase III Knee Osteoarthritis Trial

InGeneron Announces Critical In-Depth Analysis of the Results from a Recently Published 480-Patient Phase III Knee Osteoarthritis Trial
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Rheinland pfalzChristoph schmitzMarcus deayalaIngeneron incCorporate developmentJournal nature medicineKnee painCorticosteroid injectionMore questionsChristopher altOsteoarthritis cartilageNature medicineCurrent clinicalStrategy manager

InGeneron Reports Positive Long-Term Results for its Cell Therapy in Partial-Thickness Rotator Cuff Tears

InGeneron Reports Positive Long-Term Results for its Cell Therapy in Partial-Thickness Rotator Cuff Tears
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMarcus deayalaCorporate developmentIngeneron incScientific reportsExecutive chairman eckhard altCurrent clinicalStrategy manager

InGeneron Reports Positive Long-Term Results for its Cell Therapy in Partial-Thickness Rotator Cuff

Randomized controlled trial meets primary endpoint and finds statistically significant durable patient benefit 3.4 years post-treatmentHOUSTON (BUSINESS WIRE) InGeneron, Inc., a clinical-stage biotechnology company, today announced positive clinical trial data demonstrating long-term safety and efficacy of InGener.

United statesIngeneron incScientific reportsExecutive chairman eckhard altCurrent clinical

Global Interactive Response Technology (IRT) Benchmarking & Market Dynamics Report 2022 - Gain an Understanding of the IRT Solutions Being Utilized Most by Peers

/PRNewswire/ The "IRT Benchmarking & Market Dynamics (4th Ed)" report has been added to ResearchAndMarkets.com s offering. The Interactive Response.

Laura woodVendor main serviceService providerInteractive response technologyOffice hours callService providersService companiesE st office hours callOffice locationSignant health smartsignalsCompany service quality profilesClinical technology familiarityImportance of technologyCompany typeMarket dynamicsTrial supply management

New Study Reports Broad Applicability of InGeneron s Regenerative Cell Therapy System Across Patient Groups

New Study Reports Broad Applicability of InGeneron s Regenerative Cell Therapy System Across Patient Groups
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jon stoneChristoph schmitzLudwig maximilians university munichStone communications consultingHead of the department anatomyIngeneron incScientific affairs at ingeneronWall streetJournal cellsLudwig maximilians universityAdvisory medical directorChristopher altScientific affairsCurrent clinical